A new model for curing disease
We are an alliance of patients, caregivers, doctors, researchers, drug developers and entrepreneurs pioneering a new approach to curing diseases through innovative outcome-based financing.
We educate, motivate and collaborate with impact investors and payers to discover life-altering therapies and bring them to patients.
Our Target is Chronic Pancreatitis
The first disease we are attacking is pancreatitis. The world’s top pancreatic experts believe a well-funded, coordinated research and development program could lead to effective treatments.
Mission: Cure is working to make that happen. Consulting with pancreatic experts from the world’s top research and healthcare institutions, we developed a plan and are working to implement it.
Financing Based on Patient Outcomes
Promising and Cost-Effective Methods to Cure Diseases
Active Collaboration Among Stakeholders
Partnerships with Impact Investors
We cannot do this without your support.
The time is right to create a new model for curing disease. Exciting developments in genetics and data are making precision medicine a reality.
Healthcare payers are moving toward value-based funding, especially for chronic diseases. And a new generation of impact investors — seeking to generate social and not just financial returns — have made curing disease a priority.
In this Mission: Cure video, Dr. Kristen Roberts from The Ohio State University answers your frequently asked questions about vitamin deficiencies and pancreatitis. https://youtu.be/6-ocrqVYeqY Get
In this Mission: Cure patient education video, Dr. Sinead Duggan from Trinity College Dublin, Ireland explains vitamin deficiencies in pancreatitis: the importance of vitamins and
In this video by HealthUnlocked, Dr. Hernandez-Barco, medical pancreatologist at Massachusetts General hospital in Boston, answers your top 5 questions when it comes to managing